In memoriam: Joel S. Bennett
Joel S. Bennett, a blood researcher at the University of Pennsylvania, died June 21, of pancreatic cancer. He was 78.
Bennet was born in 1942 to Marvin and Rhoda Bennett and grew up in Southfield, Michigan. He graduated from the University of Michigan with a premed bachelor’s degree in 1963 and a medical degree from the University of Michigan Medical School in 1967.

After earning his M.D., Bennett went to University of Pennsylvania for a residency in internal medicine and a fellowship in hematology–oncology. Outside of briefly serving as a physician in the U.S. Air Force, Bennett remained a member of Penn’s medical and academic community for over 40 years.
Bennett’s research focused on understanding the biophysical and molecular interactions of tiny blood cells called platelets. He was the first to discover that a protein produced by the liver called fibrinogen binds platelets. This binding results in clumping and accumulation of platelets that is important for clotting and can play a role in heart attacks or strokes.
This discovery and Bennett’s other research into platelet biology contributed to the development of drugs that block platelet aggregation, commonly known as blood thinners. Today these drugs are critical to preventing blood clots in certain at-risk patients.
Bennett received various awards in recognition of his work, including the Ernest Beutler Prize from the American Society of Hematology, the society’s highest honor. He was also recognized by the Association of American Physicians and the American Society for Clinical Investigation.
According to an obituary in The Philadelphia Inquirer, Bennett is remembered by his colleagues for his scientific acumen, devotion to his patients and dedication as an educator.
Bennett is survived by his wife, Evelyn; three sons, Joe, David and Andrew Bennett; two daughters, Lisa Bennett and Lisa Dunn; a brother and sister; and nine grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Simcox and Gisriel receive mentoring award
They were honored for contributing their time, knowledge, energy and enthusiasm to mentoring postdocs in their labs.

ASBMB names 2025 Marion B. Sewer scholarship recipients
Ten undergraduates interested in biochemistry and molecular biology will each receive $2,000 toward their tuition and related educational costs.

Attie named honorary professor
This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.

Meet the 2025 SOC grant awardees
Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.